|
Chugai
intensive care for haematopoietic stem cell transplant recipients: admission and outcome Intensive Care For Haematopoietic Stem Cell Transplant Recipients: Admission And Outcome, supplied by Chugai, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/intensive care for haematopoietic stem cell transplant recipients: admission and outcome/product/Chugai Average 90 stars, based on 1 article reviews
intensive care for haematopoietic stem cell transplant recipients: admission and outcome - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
|
StemCells Inc
pkh-26 cells Pkh 26 Cells, supplied by StemCells Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/pkh-26 cells/product/StemCells Inc Average 90 stars, based on 1 article reviews
pkh-26 cells - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
|
Charite Research Organisation
tolerogenic recipient dendritic cells Tolerogenic Recipient Dendritic Cells, supplied by Charite Research Organisation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/tolerogenic recipient dendritic cells/product/Charite Research Organisation Average 90 stars, based on 1 article reviews
tolerogenic recipient dendritic cells - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
|
Cell Genesys
recipient plasmid pkc(ro − )mnd.mcs Recipient Plasmid Pkc(ro − )Mnd.Mcs, supplied by Cell Genesys, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/recipient plasmid pkc(ro − )mnd.mcs/product/Cell Genesys Average 90 stars, based on 1 article reviews
recipient plasmid pkc(ro − )mnd.mcs - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
|
Wolters Kluwer Health
donor-recipient b and t cell cdc crossmatches (xm) Donor Recipient B And T Cell Cdc Crossmatches (Xm), supplied by Wolters Kluwer Health, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/donor-recipient b and t cell cdc crossmatches (xm)/product/Wolters Kluwer Health Average 90 stars, based on 1 article reviews
donor-recipient b and t cell cdc crossmatches (xm) - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
|
Bacto Laboratories
m. capricolum recipient cells M. Capricolum Recipient Cells, supplied by Bacto Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/m. capricolum recipient cells/product/Bacto Laboratories Average 90 stars, based on 1 article reviews
m. capricolum recipient cells - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
|
CEM Corporation
uninfected recipient t-cells Uninfected Recipient T Cells, supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/uninfected recipient t-cells/product/CEM Corporation Average 90 stars, based on 1 article reviews
uninfected recipient t-cells - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
|
PermeGear Inc
franz cell system with orifice diameter of 5mm and recipient chamber volume of 1.5ml Franz Cell System With Orifice Diameter Of 5mm And Recipient Chamber Volume Of 1.5ml, supplied by PermeGear Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/franz cell system with orifice diameter of 5mm and recipient chamber volume of 1.5ml/product/PermeGear Inc Average 90 stars, based on 1 article reviews
franz cell system with orifice diameter of 5mm and recipient chamber volume of 1.5ml - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
|
Becton Dickinson
cd8 + t cells from cell cultures or transplant recipients ![]() Cd8 + T Cells From Cell Cultures Or Transplant Recipients, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cd8 + t cells from cell cultures or transplant recipients/product/Becton Dickinson Average 90 stars, based on 1 article reviews
cd8 + t cells from cell cultures or transplant recipients - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
|
Vereinigte Papierwarenfabriken GmbH
donor antigen specific regulatory t cell function and outcome in kidney transplant recipients ![]() Donor Antigen Specific Regulatory T Cell Function And Outcome In Kidney Transplant Recipients, supplied by Vereinigte Papierwarenfabriken GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/donor antigen specific regulatory t cell function and outcome in kidney transplant recipients/product/Vereinigte Papierwarenfabriken GmbH Average 90 stars, based on 1 article reviews
donor antigen specific regulatory t cell function and outcome in kidney transplant recipients - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
|
clea japan inc
mononuclear cells of hematopoietic tissues of gata-1.05 /x mice and recipient nude mice ![]() Mononuclear Cells Of Hematopoietic Tissues Of Gata 1.05 /X Mice And Recipient Nude Mice, supplied by clea japan inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/mononuclear cells of hematopoietic tissues of gata-1.05 /x mice and recipient nude mice/product/clea japan inc Average 90 stars, based on 1 article reviews
mononuclear cells of hematopoietic tissues of gata-1.05 /x mice and recipient nude mice - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
|
Salvin Dental Specialties
suppression of delayed hypersensitivity reactions in guinea pigs after lymphoid cell transfer into antigen-sensitized recipients ![]() Suppression Of Delayed Hypersensitivity Reactions In Guinea Pigs After Lymphoid Cell Transfer Into Antigen Sensitized Recipients, supplied by Salvin Dental Specialties, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/suppression of delayed hypersensitivity reactions in guinea pigs after lymphoid cell transfer into antigen-sensitized recipients/product/Salvin Dental Specialties Average 90 stars, based on 1 article reviews
suppression of delayed hypersensitivity reactions in guinea pigs after lymphoid cell transfer into antigen-sensitized recipients - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Immunology
Article Title: Interferon regulatory factor 4 deficiency in CD8 + T cells abrogates terminal effector differentiation and promotes transplant acceptance
doi: 10.1111/imm.13258
Figure Lengend Snippet: IRF4 expression in WT CD8+ T cells is positively correlated with the production of effector molecules. Splenocytes from WT B6 mice were stimulated with 2 µg/ml soluble anti‐CD3e mAb for 24 h, followed by flow cytometric analysis. All contour plots were gated on living CD8+ T cells. (A) Schematic of the experimental design. (B,C) Representative contour plots and bar graphs display the IRF4 expression of CD127+KLRG1−, CD127−KLRG1− and CD127−KLRG1+ CD8+ T‐cell subsets. (D,E) Representative contour plots and bar graphs show the expression of IFN‐γ and granzyme B in CD8+ T‐cell subpopulations that express high, medium or low levels of IRF4. Data are mean ± SD (n = 5). **p < 0.01, ****p < 0.0001 (unpaired Student's t‐test)
Article Snippet: In brief,
Techniques: Expressing
Journal: Immunology
Article Title: Interferon regulatory factor 4 deficiency in CD8 + T cells abrogates terminal effector differentiation and promotes transplant acceptance
doi: 10.1111/imm.13258
Figure Lengend Snippet: Irf4‐deficient CD8+ T cells are capable of recognizing BALB/c alloantigens. Irf4‐deficient or control CD8+ T cells were stimulated by B6 or BALB/c APCs for 72 h, supplemented with or without murine IL‐2. All contour plots were gated on the living CD8+ T cells. (A,B) % CD62L−CD44+ cells among the living CD8+ T cells in response to B6 or BALB/c stimulators. (C,D) % CD69+ cells among the living CD8+ T cells in response to B6 or BALB/c stimulators. (E,F) % Nur77+Ki67+ cells among the living CD8+ T cells in response to B6 or BALB/c stimulators. Data are mean ± SD (n = 5). ns, no significance; **p < 0.01, ****p < 0.0001 (unpaired Student's t‐test). APC, antigen‐presenting cell
Article Snippet: In brief,
Techniques:
Journal: Immunology
Article Title: Interferon regulatory factor 4 deficiency in CD8 + T cells abrogates terminal effector differentiation and promotes transplant acceptance
doi: 10.1111/imm.13258
Figure Lengend Snippet: IRF4 deletion in CD8+ T cells abrogates their function in rejecting skin allografts. Lymphopenic B6.Rag1−/− recipients were adoptively transferred with either 5 × 105 Irf4‐deficient CD8+ T cells isolated from Irf4 fl/fl Cd4‐Cre mice, or 5 × 105 control CD8+ T cells obtained from Irf4 fl/fl mice. One day later, B6.Rag1−/− recipients were transplanted with fully MHC‐mismatched skin allografts from BALB/c donors. (A) Schematic of the experimental design. Tx, transplantation. (B) The percentage of graft survival post‐allogeneic tail skin transplantation (n = 5). **p < 0.01; Mann–Whitney test. (C) Representative images of a rejected skin graft on a recipient that received control CD8+ T cells (left image), and accepted skin grafts on recipients that received Irf4‐deficient CD8+ T cells (middle and right images) at indicated days post‐skin grafting
Article Snippet: In brief,
Techniques: Isolation, Transplantation Assay, MANN-WHITNEY
Journal: Immunology
Article Title: Interferon regulatory factor 4 deficiency in CD8 + T cells abrogates terminal effector differentiation and promotes transplant acceptance
doi: 10.1111/imm.13258
Figure Lengend Snippet: IRF4 deletion in CD8+ T cells completely abolishes their terminal effector differentiation in transplant recipients. B6.Rag1−/− recipients were adoptively transferred with either Irf4‐deficient (Irf4 fl/fl Cd4‐Cre) or control (Irf4 fl/fl) CD8+ T cells, followed by BALB/c skin transplantation. Adoptively transferred CD8+ T cells in spleens and DLNs were analysed at day 14 post‐skin grafting. All contour plots were gated on the living transferred CD8+ T cells. (A,B) Representative contour plots and bar graph display the % CD127−KLRG1+ terminal effector cells among the transferred CD8+ T cells. (C,D), Representative contour plots and bar graph display the % CD62L−CX3CR1+ effector cells among the transferred CD8+ T cells. Data are mean ± SD (n = 3). ****p < 0.0001 (unpaired Student's t‐test)
Article Snippet: In brief,
Techniques: Transplantation Assay
Journal: Immunology
Article Title: Interferon regulatory factor 4 deficiency in CD8 + T cells abrogates terminal effector differentiation and promotes transplant acceptance
doi: 10.1111/imm.13258
Figure Lengend Snippet: Irf4‐deficient CD8+ T cells barely produce proinflammatory cytokines and cytotoxic molecules in transplant recipients. At day 14 post‐BALB/c skin grafting, the adoptively transferred Irf4‐deficient and control CD8+ T cells in B6.Rag1−/− recipients were analysed. All contour plots were gated on the living transferred CD8+ T cells. (A,B) % IFN‐γ+ TNF‐α+ cells among the transferred CD8+ T cells in spleens and DLNs. (C,D) Percentage of granzyme B+ cells among the transferred CD8+ T cells in spleens and DLNs. (E,F) % IL‐2+ and % granzyme A+ cells among the transferred CD8+ T cells. Data are mean ± SD (n = 3). *p < 0.05; **p < 0.01, ***p < 0.001; ****p < 0.0001 (unpaired Student's t‐test)
Article Snippet: In brief,
Techniques:
Journal: Immunology
Article Title: Interferon regulatory factor 4 deficiency in CD8 + T cells abrogates terminal effector differentiation and promotes transplant acceptance
doi: 10.1111/imm.13258
Figure Lengend Snippet: Irf4‐deficient CD8+ T cells exhibit low frequency and low Ki67 expression in transplant recipients. At day 14 post‐BALB/c skin grafting, the adoptively transferred Irf4‐deficient and control CD8+ T cells in B6.Rag1−/− recipients were analysed. All contour plots and overlay histograms were gated on the living transferred CD8+ T cells in spleens. (A,B) Representative plots and bar graph display the percentage of the transferred CD8+ T cells among CD45+ immune cells. (C‐D) Representative plots and bar graphs display MFI Ki67 among the transferred CD8+ T cells. Data are mean ± SD (n = 3). **p < 0.01 (unpaired Student's t‐test)
Article Snippet: In brief,
Techniques: Expressing
Journal: Immunology
Article Title: Interferon regulatory factor 4 deficiency in CD8 + T cells abrogates terminal effector differentiation and promotes transplant acceptance
doi: 10.1111/imm.13258
Figure Lengend Snippet: IRF4 deficiency in CD8+ T cells affects the expression of key transcription factors that control terminal effector differentiation. At day 14 post‐BALB/c skin grafting, the adoptively transferred Irf4‐deficient and control CD8+ T cells in B6.Rag1−/− recipients were analysed. All overlay histograms and contour plots were gated on the living transferred CD8+ T cells in spleens. Representative overlay histograms and bar graphs show T‐bet (A,B) and ID2 (C,D) expression levels of the transferred CD8+ T cells. Representative contour plots and bar graphs show % TCF1+ (E,F) and % EOMES+ (G,H) cells among the transferred CD8+ T cells. Data are mean ± SD (n = 3). *p < 0.05; **p < 0.01, ***p < 0.001; (unpaired Student's t‐test)
Article Snippet: In brief,
Techniques: Expressing
Journal: Immunology
Article Title: Interferon regulatory factor 4 deficiency in CD8 + T cells abrogates terminal effector differentiation and promotes transplant acceptance
doi: 10.1111/imm.13258
Figure Lengend Snippet: Naïve Irf4‐deficient CD8+ T cells barely differentiate into terminal effector cells and fail to reject skin allografts. B6.Rag1−/− recipients were adoptively transferred with naïve Irf4‐deficient or control CD8+ T cells, and transplanted with BALB/c tail skins or left without transplantation. (A) Schematic of the experimental design. (B) Representative contour plots display the purified CD44low naïve CD8 T cells prior to adoptive transfer. (C) The percentage of graft survival post‐transplantation (n = 6). ***p < 0.001; Mann–Whitney test. (D) Representative H&E staining images (×200) of the skin grafts on recipients that received naïve control (left image) or naïve Irf4‐deficient (right image) CD8+ T cells at day 14 post‐grafting. (E,F) Representative contour plots and graphs show % CD8+ cells among CD45.2+ immune cells, and the absolute number of CD8+ cells in spleens on day 14 post‐grafting. (G,H) Representative contour plots and the graph display % CD127−KLRG1+ cells among the transferred CD8+ T cells. Data are mean ± SD (n = 4). ns, no significance; *p < 0.05; ***p < 0.001; ****p< 0.0001 (unpaired Student's t‐test). Tx, transplantation
Article Snippet: In brief,
Techniques: Transplantation Assay, Purification, Adoptive Transfer Assay, MANN-WHITNEY, Staining
Journal: Immunology
Article Title: Interferon regulatory factor 4 deficiency in CD8 + T cells abrogates terminal effector differentiation and promotes transplant acceptance
doi: 10.1111/imm.13258
Figure Lengend Snippet: Irf4‐deficient CD8+ T cells fail to acquire terminal effector phenotypes in recipients with long‐term accepted allografts. B6.Rag1−/− recipients were adoptively transferred with either Irf4‐deficient or control CD8+ T cells, followed by BALB/c skin transplantation. Adoptively transferred CD8+ T cells in spleens were analysed by flow cytometry at day 100 post‐skin grafting. (A,B) Representative contour plots and bar graphs show % CD8+ T cells among CD45.2+ immune cells (A,B left bar graph), and absolute CD8+ T cells in spleens (B right bar graph). (C‐J) Contour plots were gated on the living transferred CD8+ T cells in spleens. Representative contour plots and bar graphs show % CD127−KLRG1+ (C,D), CD62L−CX3CR1+ (E,F), IFN‐γ+ (G,H), TCF1+ (I,J left bar graph) and EOMES+ (i,j right bar graph) cells among the adoptively transferred CD8+ T cells. Data are mean ± SD of n ≥ 3 animals per group. ns, no significance; *p < 0.05; **p < 0.01; ****p < 0.0001 (unpaired Student's t‐test)
Article Snippet: In brief,
Techniques: Transplantation Assay, Flow Cytometry